Healthcare major Apollo Hospitals on 30 September 2014 tied up with the global pharma firm Sanofi. The aim behind this tie-up is to expand Apollo Sugar Clinics which provide integrated diabetes care programmes in India.
Through this collaboration, Apollo and Sanofi plan to leverage their respective expertise in diabetes to provide patients with access to comprehensive educational resources, treatment and care programmes for better management.
Under this collaboration, the plan is to roll out another 150 clinics over the period of next two three years with an investment of 30-60 lakh rupees each.
Diabetes in India
Globally, Diabetes has affected close to 382 million people with India alone accounting for over 65 million people affected with diabetes (III). Around 77.2 million people were diagnosed as being pre-diabetic.
As per estimates, an average person with diabetes in urban India spends approximately 30000 rupees per year on treatment. In cases of late diagnosis, it results in 10-18 times higher spending.
The number of people with diabetes in India is expected to rise to 109 million by 2035. Such scenario demands for quick actions and a sense of purpose to arrest the disease from claiming more lives.
• In 1718, Laboratoires Midy was founded by a family of pharmacists. In 1980, the this Midy group was acquired by Sanofi.
• Sanofi is a global healthcare leader that focuses on the needs of the patients. It is engaged in the research, development, manufacturing and marketing of innovative therapeutic solutions.
• Sanofi has core strengths in healthcare with 7 growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.
• Apollo Hospitals was inaugurated in 1983 by Shri Giani Zail Singh (President of India). The first Apollo Hospital was in Chennai. The hospital commenced commercial operations in 1984.
• It aims to bring healthcare of International standards within the reach of every individual.
• Today, it has over 10000 beds across 51 hospitals, more than 1500 pharmacies, over 100 primary care & diagnostic clinics, 115 telemedicine units across 9 countries, health insurance services, global projects consultancy, 15 academic institutions and a Research Foundation.
When: 30 September 2014
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.